Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
Terminated
National Institute of Mental Health (NIMH)
Phase 4
2008-08-01
This study will examine whether combined use of an antidepressant medication and the
medication nimodipine reduces risk of depression relapse in patients with vascular
depression.
Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
Terminated
University of Pittsburgh
Phase 4
2008-08-01
This study will examine whether combined use of an antidepressant medication and the
medication nimodipine reduces risk of depression relapse in patients with vascular
depression.
Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients
Terminated
Mount Sinai Hospital, Canada
Phase 2
2012-12-01
Nimodipine (Nimotop® Bayer Pharmaceuticals Corporation), unlike other calcium channel
blockers is fat soluble and therefore is able to cross the blood-brain barrier1. Gonadotropin
releasing hormone (GnRH) neurons are clustered in the hypothalamus and are dependent on
calcium flux to release GnRH responsible for the release of follicle-stimulating hormone
(FSH) and luteinizing hormone (LH) from the anterior pituitary. In a natural menstrual cycle
a spontaneous LH surge occurs mid-cycle which triggers ovulation. The investigators
hypothesized that nimodipine, by blocking calcium channels, may effectively suppress the
release of GnRH and consequently the natural LH surge.
In this prospective double-blinded randomized study the investigators will evaluate the
efficacy of nimodipine to inhibit the natural LH surge in women undergoing controlled ovarian
stimulation (COS) and intrauterine insemination (IUI). Nimodipine, if successful, may
represent an inexpensive oral medication as an alternative to the currently used GnRH
agonists or GnRH antagonists in assisted reproductive technologies like IVF.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
